National Health Investors added $30.6 million of revenue in the three months ended June 30, a 34% increase from the comparable period. Net income rose even faster, up 51% to $55.7 million. The stock barely moved, down 0.1% at the latest close of $75.41.
The less tidy number is cash. Operating cash flow rose 11%, from $106.3 million to $118.4 million, well behind the jump in revenue and net income. NHI is growing, but the cash arriving from that growth is moving at a different speed.
Management points to two engines: acquisitions in both business segments and rent increases already written into tenant leases. The latter gives the revenue line a built-in escalator, rather than leaving every dollar to the mercy of new deals.
The company describes that lease machinery this way:
"Inflation Risk Our tenant leases generally provide for annual escalators in the contractual amounts of base rent due to us which are calculated using a fixed rate of increase or a variable index, such as the consumer price index (“CPI”)."
10-Q 2026-08-10
In plain English, some rent growth is contractual. That helps explain why revenue increased 33.8% even as diluted shares rose 3.6% to 48.5 million. Stock compensation also more than doubled to $2.4 million, and compensation as a share of revenue increased 1.9 percentage points.
The six-month cash-flow disclosure makes the acquisition effect explicit:
"Operating Activities – Net cash provided by operating activities for the six months ended June 30, 2026 included increased revenues, net of operating expenses, as a result of our acquisitions activity in both segments and increased revenues resulting from the annual rent escalators on our existing tenant leases."
10-Q 2026-08-10
That sentence supplies the bridge between the headline growth and the cash result. It also makes the comparison less purely organic: NHI is collecting more from existing properties while adding assets through acquisitions. The three-month figures show the result, but do not split the revenue increase between those two sources.
The expense lines were not all moving in the same direction. Legal expense fell by $1.8 million, or 70.2%, because the prior-year period included costs tied to a large SHOP transaction that did not materialize and the transition of seven properties. That is a meaningful lift to the comparison, but it is not a recurring rent escalator.
Interest expense moved the other way, increasing $0.8 million, including $4.7 million from the 2033 Senior Notes issued in September 2025. Repayments of other debt and lower rates on variable-rate debt partly offset that increase. NHI's net margin still expanded from 40.8% to 45.9%, helped by revenue growth and the lower legal bill, while the balance sheet ended the period with $30.4 million of cash, up from $18.6 million.
The market context adds a separate tension. NHI has a $3.5 billion market cap and trades at 25.0 times earnings, while its annual revenue reached $80.1 million in 2025 after rising 47.1%. Most of the disagreement about the stock is therefore about the price attached to the earnings, not whether the recent sales path is expanding.
NHI's next three-month report will leave one clean comparison: whether operating cash flow moves beyond the $118.4 million recorded in this period, as acquisitions and contractual rent increases continue to appear in the numbers.
Source: National Health Investors 10-Q filed August 10, 2026.